ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy
Pathology - Research and Practice · 2026
DOI: 10.1016/j.prp.2026.156457 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Biplab Debnath und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal 711316, India. Hauptthemen laut MEDLINE: Stem Cell Transplantation, Metabolic Diseases, Reactive Oxygen Species. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 220 Literaturangaben.
Abstract (Originalsprache)
Metabolic disorders refer to a range of conditions that interfere with the body's normal metabolic processes, including obesity, diabetes, cardiovascular diseases, mitochondrial dysfunction, and certain kinds of cancer. These disorders are usually caused by an imbalance in energy regulation, nutrient processing, or cellular homeostasis. Increasingly, reactive oxygen species (ROS) have been recognised as essential contributor to the early pathogenesis of various metabolic diseases. ROS, secondary metabolites generated during cellular metabolism, are closely associated with oxidative stress, which leads to cellular damage and dysfunction. Excessive ROS generation disrupts normal metabolic processes such as lipid metabolism, insulin signaling, and mitochondrial function, thereby contributing to the development and progression of these disorders. Currently, stem cell (SC) therapy has emerged as promising approach for the management of several metabolic disorders. This review explores the involvement of ROS in metabolic disorders and the application of SCs along with antioxidants, to mitigate oxidative stress-induced metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal 711316, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
- NSHM Institute of Pharmaceutical Technology, NSHM Knowledge Campus, Durgapur, West Bengal 713212, India.
- Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India.
- Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Sciences-Tezpur Campus, Assam 784501, India.
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal 711316, India. Electronic address: ashiquesumel007@gmail.com.
Zitieren
APA
Debnath, B., Das, J., Bhui, U., Dewan, D., Paul, D., Mondal, M., Islam, A., Bhattacharjee, B., Ashique, S., & Hussain, M. S. (2026). ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156457
Vancouver
Debnath B, Das J, Bhui U, Dewan D, Paul D, Mondal M, et al. ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2026.156457
BibTeX
@article{Debnath2026,
author = {Debnath, Biplab and Das, Joy and Bhui, Utpal and Dewan, Debajit and Paul, Debasmita and Mondal, Mohini and Islam, Anas and Bhattacharjee, Bedanta and Ashique, Sumel and Hussain, Md Sadique},
title = {ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy},
journal = {Pathology - Research and Practice},
year = {2026},
doi = {10.1016/j.prp.2026.156457}
}
EUVIMED